Michal Fisher
Director · CNS Pharmaceuticals, Inc.
IndividualBuying only
- 2026
- Aug 18, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michal Fisher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Faith L. Charles - $34K in CNSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michal Fisher?
Michal Fisher is a corporate insider, tracked as Director of CNS Pharmaceuticals, Inc. (CNSP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michal Fisher submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michal Fisher been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 0 open-market sales across all tracked filings.
